Photo of Pei-Ming Yang

View Scopus Profile

Pei-Ming Yang

Associate Professor

 https://orcid.org/0000-0002-4004-2518
  • 3652 Citations
  • 18 h-Index
20042020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2006, Ph.D. (Life Science), National Tsing Hua University
  • 2000, B.S. (Life Science), National Tsing Hua University

Experience

  • 2019- Associate Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
  • 2018- Associate Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
  • 2016-2018 Associate Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
  • 2012-2016 Assistant Professor, The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University
  • 2007-2009 Postdoctoral fellow, National Taiwan University College of Medicine

Awards

  • 2012 Young Investigator Award, The Pharmacological Society in Taiwan

Research Interests

  • Cancer Biology
  • Pharmacology
  • Epigenetics

URL

Fingerprint Dive into the research topics where Pei-Ming Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

透過老藥新用策略來開發以Stathmin 1為標靶之抗肝癌新藥

Yang, P.

3/1/20 → 2/28/21

Project: C - Project of Alliance › n - Yuan's General Hospital

長鏈非編碼核糖核酸LncHIFCAR/MIR31HG調控的中心網絡在胰臟癌的轉譯研究-探討MIR31HG 調控胰臟癌EMT 及藥物治療反應之作用

Yang, P.

1/1/19 → 12/1/19

Project: A - Government Institution › d - Ministry of Education

探討miR-21調控大腸直腸癌細胞 TET1/5- hydroxymethylcytosine表現對其化療反應之關聯(2/3)(相對補助)

Yang, P.

8/1/16 → 7/31/17

Project: A - Government Institution › f - Other (Funded by Government)

不同APC基因狀態大腸直腸癌患者藥物治療之抗藥性機轉研究-探討miR-21調控大腸直腸癌細胞TET1/5-hydroxymethylcytosine表現對其化療反應之關聯(3/3)

Yang, P.

8/1/16 → 7/31/17

Project: A - Government Institution › b - Ministry of Science and Technology

Role of miR-21 in Regulating TET I-Hydroxymethylcytosine and Chemotherapeutic Response in Colorectal Cancer (II)

Yang, P.

8/1/15 → 7/31/16

Project: A - Government Institution › b - Ministry of Science and Technology

Research Output

  • 3652 Citations
  • 18 h-Index
  • 47 Article
  • 2 Comment/debate
  • 2 Review article
  • 1 Editorial

Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer

Chen, C. H., Hsieh, Y. C., Yang, P. M., Liu, Y. R. & Cho, E. C., 2020, In : Biochemical and Biophysical Research Communications.

Research output: Contribution to journal › Article

    • Overexpression of miR-21-5p in colorectal cancer cells promotes self-assembly of E-cadherin-dependent multicellular tumor spheroids

    Li, A. & Yang, P. M., Aug 2020, In : Tissue and Cell. 65, 101365.

    Research output: Contribution to journal › Article

    • Sequential interferon β-cisplatin treatment enhances the surface exposure of calreticulin in cancer cells via an interferon regulatory factor 1-dependent manner

    Yang, P. M., Hsieh, Y. Y., Du, J. L., Yen, S. C. & Hung, C. F., Apr 2020, In : Biomolecules. 10, 4, 643.

    Research output: Contribution to journal › Article

    Open Access

    • Sorafenib inhibits ribonucleotide reductase regulatory subunit M2 (RRM2) in hepatocellular carcinoma cells

    Yang, P. M., Lin, L. S. & Liu, T. P., Jan 2020, In : Biomolecules. 10, 1, 117.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Citation (Scopus)

    An integrated bioinformatics analysis repurposes an antihelminthic drug niclosamide for treating hmga2-overexpressing human colorectal cancer

    Leung, S. W., Chou, C. J., Huang, T. C. & Yang, P. M., Oct 2019, In : Cancers. 11, 10, 1482.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Citations (Scopus)